2.45 (-%)
As of Nov 22, 2024
Source:
Nkarta, Inc is a clinical-stage biopharmaceutical company advancing the development of allogeneic, off-the-shelf engineered natural killer cell therapies for the treatment of patients with autoimmune diseases or hematologic malignancies.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | (925) 407-1049 |
| Industry | manufacturing |
| CEO | Paul J. Hastings |
| Website | www.nkartatx.com |